Dali Pharmaceuticalco.Ltd's high P/S ratio may not be justif...
Dali Pharmaceuticalco.Ltd's high P/S ratio may not be justified due to declining revenue. The market might be overvaluing its potential, risking shareholder disappointment if the ratio aligns with recent negative growth rates.
More Unpleasant Surprises Could Be In Store For Dali Pharmaceuticalco.,Ltd's (SHSE:603963) Shares After Tumbling 26%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4226Followers
0Following
9278Visitors
Follow